Kumiko Goi

2.2k total citations
78 papers, 1.2k citations indexed

About

Kumiko Goi is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Kumiko Goi has authored 78 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Hematology, 29 papers in Public Health, Environmental and Occupational Health and 26 papers in Molecular Biology. Recurrent topics in Kumiko Goi's work include Acute Lymphoblastic Leukemia research (28 papers), Chronic Myeloid Leukemia Treatments (23 papers) and Chronic Lymphocytic Leukemia Research (11 papers). Kumiko Goi is often cited by papers focused on Acute Lymphoblastic Leukemia research (28 papers), Chronic Myeloid Leukemia Treatments (23 papers) and Chronic Lymphocytic Leukemia Research (11 papers). Kumiko Goi collaborates with scholars based in Japan, United States and Italy. Kumiko Goi's co-authors include Takeshi Inukai, Kanji Sugita, Toshiya Inaba, Hidemitsu Kurosawa, Keiko Kagami, K Sugita, Shinpei Nakazawa, K Kagami, S Nakazawa and Tetsuharu Shinjyo and has published in prestigious journals such as Blood, Molecular Cell and Molecular and Cellular Biology.

In The Last Decade

Kumiko Goi

72 papers receiving 1.2k citations

Peers

Countries citing papers authored by Kumiko Goi

Since Specialization

Citations

This map shows the geographic impact of Kumiko Goi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kumiko Goi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kumiko Goi more than expected).

Fields of papers citing papers by Kumiko Goi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kumiko Goi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kumiko Goi. The network helps show where Kumiko Goi may publish in the future.

Co-authorship network of co-authors of Kumiko Goi

This figure shows the co-authorship network connecting the top 25 collaborators of Kumiko Goi. A scholar is included among the top collaborators of Kumiko Goi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kumiko Goi. Kumiko Goi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A characteristic gene expression profile regulated by ACIN1::NUTM1 fusion in a newly identified infant leukaemic cell line and an ACIN1 :: NUTM1 ‐inducible model 2025 ·British Journal of Haematology ·Minori Tamai, (unknown), (unknown), (unknown), Atsushi Watanabe, Koshi Akahane, Kumiko Goi, (unknown), Toshihiko Imamura, Satoshi Oguri, Sumio Iwasaki, Takanori Teshima, Yasushi Yatabe, Takeshi Inukai	0
2	Multifocal osteonecrosis as well as repeated bone fractures due to osteoporosis in a prepubertal ALL case 2025 ·Pediatrics International ·(unknown), (unknown), Atsushi Watanabe, Koshi Akahane, Masanori Wako, Kumiko Goi, Takeshi Inukai	0
3	Utility of a Large Series of B‐Cell Precursor Acute Lymphoblastic Leukemia Cell Lines as a Model System 2025 ·Cancer Medicine ·Minori Tamai, (unknown), Keiko Kagami, (unknown), Koshi Akahane, Kumiko Goi, Kanji Sugita, (unknown), Toshihiko Imamura, Hiroaki Goto, Takeshi Inukai	1
4	Application of prime editing system to introduce TP53 R248Q hotspot mutation in acute lymphoblastic leukemia cell line 2024 ·Cancer Science ·Thao Nguyen, Tomomi Aida, Yuka Iijima‐Yamashita, Minori Tamai, Akiko Nagamachi, (unknown), (unknown), (unknown), Koshi Akahane, Kumiko Goi, Toshiya Inaba, Masashi Sanada, Takeshi Inukai	3
5	CRISPR/Cas9-Mediated Induction of Relapse-Specific NT5C2 and PRPS1 Mutations Confers Thiopurine Resistance as a Relapsed Lymphoid Leukemia Model 2023 ·Molecular Pharmacology ·Thao Nguyen, Yoïchi Tanaka, Masashi Sanada, (unknown), Minori Tamai, Keiko Kagami, (unknown), (unknown), Daisuke Harama, (unknown), Atsushi Watanabe, (unknown), Kumiko Goi, Takeshi Inukai	1
6	Utility of ASNS gene methylation evaluated with the HPLC method as a pharmacogenomic biomarker to predict asparaginase sensitivity in BCP-ALL 2023 ·Epigenetics ·Atsushi Watanabe, Kunio Miyake, (unknown), (unknown), (unknown), (unknown), (unknown), Minori Tamai, Daisuke Harama, Koshi Akahane, Kumiko Goi, Kimiyoshi Sakaguchi, Hiroaki Goto, (unknown), Takeshi Inukai	2
7	Glucocorticoid receptor gene mutations confer glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia 2022 ·The Journal of Steroid Biochemistry and Molecular Biology ·Minori Tamai, (unknown), Koshi Akahane, Thao Nguyen, Keiko Kagami, (unknown), Masako Abe, Atsushi Watanabe, Kumiko Goi, Kunio Miyake, Toshiya Inaba, Junko Takita, Hiroaki Goto, Masayoshi Minegishi, Shotaro Iwamoto, Kanji Sugita, Takeshi Inukai	7
8	Creation of Philadelphia chromosome by CRISPR/Cas9-mediated double cleavages on BCR and ABL1 genes as a model for initial event in leukemogenesis 2022 ·Cancer Gene Therapy ·Minori Tamai, Shinichi Fujisawa, Thao Nguyen, (unknown), Keiko Kagami, Kenji Kamimoto, Kohei Omachi, (unknown), Daisuke Harama, Atsushi Watanabe, Koshi Akahane, Kumiko Goi, Kazuhito Naka, Tadashi Kaname, Takanori Teshima, Takeshi Inukai	2
9	Introduction of the T315I gatekeeper mutation of BCR/ABL1 into a Philadelphia chromosome-positive lymphoid leukemia cell line using the CRISPR/Cas9 system 2022 ·International Journal of Hematology ·Thao Nguyen, Minori Tamai, Daisuke Harama, Keiko Kagami, (unknown), Atsushi Watanabe, Koshi Akahane, Kumiko Goi, Takeshi Inukai	3
10	Epigenetic Modification of Death Receptor Genes for TRAIL and TRAIL Resistance in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia 2021 ·Genes ·Atsushi Watanabe, Kunio Miyake, Koshi Akahane, Kumiko Goi, Keiko Kagami, Hideo Yagita∥, Takeshi Inukai	6
11	Association of relapse-linked ARID5B single nucleotide polymorphisms with drug resistance in B-cell precursor acute lymphoblastic leukemia cell lines 2020 ·Cancer Cell International ·Minori Tamai, Meixian Huang, Keiko Kagami, Masako Abe, (unknown), (unknown), Daisuke Harama, Atsushi Watanabe, Koshi Akahane, Kumiko Goi, Kanji Sugita, Hiroaki Goto, Masayoshi Minegishi, Shotaro Iwamoto, Takeshi Inukai	5
12	Inflammatory mediator ultra-low-molecular-weight hyaluronan triggers necrosis of B-precursor leukemia cells with high surface CD44 expression 2017 ·Cell Death and Disease ·(unknown), (unknown), (unknown), Keiko Kagami, Masako Abe, Takaya Nakane, Kumiko Goi, Takeshi Inukai, Sei Saitoh, Shinichi Ohno, Shogo Okazaki, Osamu Nagano, Hideyuki Saya, Kanji Sugita	8
13	Specific Antileukemic Activity of PD0332991, a CDK4/6 Inhibitor, against Philadelphia Chromosome–Positive Lymphoid Leukemia 2015 ·Molecular Cancer Therapeutics ·Atsushi Nemoto, Satoshi Saida, Itaru Kato, Jiro Kikuchi, Yusuke Furukawa, Yasuhiro Maeda, Koshi Akahane, (unknown), Kumiko Goi, Keiko Kagami, Shinya Kimura, Yuko Sato, Seiichi Okabe, Akira Niwa, Kenichiro Watanabe, Tatsutoshi Nakahata, Toshio Heike, Kanji Sugita, Takeshi Inukai	20
14	Pre-B-Cell Acute Lymphoblastic Leukemia in a Boy with Hereditary Multiple Exostoses Caused byEXT1Deletion 2014 ·Pediatric Hematology and Oncology ·Takaya Nakane, Kumiko Goi, (unknown), Chihiro Kobayashi, Hidenori Sato, Takeo Kubota, Kanji Sugita	2
15	Oncogenic fusion E2A-HLF sensitizes t(17;19)-positive acute lymphoblastic leukemia to TRAIL-mediated apoptosis by upregulating the expression of death receptors 2012 ·Leukemia ·Xiaoliu Zhang, Takeshi Inukai, (unknown), Koshi Akahane, (unknown), (unknown), K Kagami, Kumiko Goi, Kazuhiro Nakamura, Masao Kobayashi, Makoto Endo, Hideo Yagita∥, Hidemitsu Kurosawa, A. Thomas Look, H. Honda, Toshiya Inaba, S Nakazawa, K Sugita	11
16	Fms-like Tyrosine Kinase 3 Ligand Stimulation Induces MLL -Rearranged Leukemia Cells into Quiescence Resistant to Antileukemic Agents 2007 ·Cancer Research ·(unknown), Kumiko Goi, Takeshi Inukai, Hiroki Sato, Atsushi Nemoto, Kazuya Takahashi, Koshi Akahane, (unknown), (unknown), (unknown), Xiaochun Zhang, Keiko Kagami, Yasuhide Hayashi, Kenichi Harigaya, Shinpei Nakazawa, Kanji Sugita	24
17	Induction of Impaired Membrane Phospholipid Asymmetry in Mature Erythrocytes after Chemotherapy 2005 ·International Journal of Hematology ·Xiaochun Zhang, Takeshi Inukai, (unknown), Koshi Akahane, Atsushi Nemoto, Kazuya Takahashi, Hiroki Sato, Keiko Kagami, Kumiko Goi, Kanji Sugita, Shinpei Nakazawa	7
18	Ligand activation of peroxisome proliferator-activated receptor γ induces apoptosis of leukemia cells by down-regulating the c-myc gene expression via blockade of the Tcf-4 activity 2002 ·Cell Death and Differentiation ·(unknown), K Sugita, Takeshi Inukai, Kumiko Goi, Masaki Nakamura, (unknown), Hiroshi Sato, K Kagami, Nick Barker, S Nakazawa	58
19	p16/MTS1/INK4A gene is frequently inactivated by hypermethylation in childhood acute lymphoblastic leukemia with 11q23 translocation 1999 ·Leukemia ·Makoto Nakamura, K Sugita, Takeshi Inukai, Kumiko Goi, (unknown), Tohru Tezuka, Satoru Kojika, Kiyono Shiraishi, (unknown), (unknown), K Kagami, (unknown), Takahiro Mori, S Nakazawa	46
20	Development of Acute Lymphoblastic Leukemia with Translocation (4;11) in a Young Girl with Familial Pericentric Inversion 12 1999 ·Cancer Genetics and Cytogenetics ·Kumiko Goi, Kanji Sugita, Makoto Nakamura, (unknown), (unknown), (unknown), Shinpei Nakazawa	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact